Empagliflozin PBS expansion will cover all HF patients
The listing will cover all patients with symptomatic heart failure across the ejection fraction spectrum.
The PBS listing for empagliflozin will soon be expanded to cover all patients with symptomatic heart failure regardless of ejection fraction.
From 1 November, doctors can issue PBS scripts for 10mg daily empagliflozin (Jardiance) for heart failure with left ventricular ejection fraction (LVEF) greater than 40% as an adjunct to standard therapy.
